Ronald Kevin Dela Cruz, OTR/L | |
766 Broad St, Shrewsbury, NJ 07702-4203 | |
(855) 428-8246 | |
Not Available |
Full Name | Ronald Kevin Dela Cruz |
---|---|
Gender | Male |
Speciality | Occupational Therapist |
Location | 766 Broad St, Shrewsbury, New Jersey |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386422905 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 46TR01133100 (New Jersey) | Primary |
Provider Name | Atlantic Physical Therapy Center |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1801857917 PECOS PAC ID: 8820168123 Enrollment ID: O20080529000248 |
News Archive
On 8 May an editorial about the Reduction by Dutasteride of Prostate Cancer Events trial by Fritz H. Schröder and Monique J. Roobol was published in the online version of European Urology, the scientific journal of the European Association of Urology.
The prices of leading cancer drugs have risen at rates far outstripping inflation over the last two decades, according to a new study co-authored by an MIT economist - but the exact reasons for the cost increases are unclear.
Paladin Labs Inc. and Somaxon Pharmaceuticals, Inc. today announced that Paladin has filed a New Drug Submission (NDS) that has been accepted for review by Health Canada for Silenor (doxepin) for the treatment and symptomatic relief of insomnia.
Although genetics is the most significant known determinant of human intelligence, how specific genes affect intelligence remains largely unknown. A multi-institution team led by a University of Utah USTAR researcher has found that the brain gene STX1A plays a significant role in the level of intelligence displayed by patients with Williams Syndrome.
› Verified 2 days ago
Provider Name | Attain Physical Therapy |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1609406438 PECOS PAC ID: 6305272659 Enrollment ID: O20200204001837 |
News Archive
On 8 May an editorial about the Reduction by Dutasteride of Prostate Cancer Events trial by Fritz H. Schröder and Monique J. Roobol was published in the online version of European Urology, the scientific journal of the European Association of Urology.
The prices of leading cancer drugs have risen at rates far outstripping inflation over the last two decades, according to a new study co-authored by an MIT economist - but the exact reasons for the cost increases are unclear.
Paladin Labs Inc. and Somaxon Pharmaceuticals, Inc. today announced that Paladin has filed a New Drug Submission (NDS) that has been accepted for review by Health Canada for Silenor (doxepin) for the treatment and symptomatic relief of insomnia.
Although genetics is the most significant known determinant of human intelligence, how specific genes affect intelligence remains largely unknown. A multi-institution team led by a University of Utah USTAR researcher has found that the brain gene STX1A plays a significant role in the level of intelligence displayed by patients with Williams Syndrome.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Ronald Kevin Dela Cruz, OTR/L 73 Kingfisher Ct, Marlboro, NJ 07746-2504 Ph: (732) 754-5346 | Ronald Kevin Dela Cruz, OTR/L 766 Broad St, Shrewsbury, NJ 07702-4203 Ph: (855) 428-8246 |
News Archive
On 8 May an editorial about the Reduction by Dutasteride of Prostate Cancer Events trial by Fritz H. Schröder and Monique J. Roobol was published in the online version of European Urology, the scientific journal of the European Association of Urology.
The prices of leading cancer drugs have risen at rates far outstripping inflation over the last two decades, according to a new study co-authored by an MIT economist - but the exact reasons for the cost increases are unclear.
Paladin Labs Inc. and Somaxon Pharmaceuticals, Inc. today announced that Paladin has filed a New Drug Submission (NDS) that has been accepted for review by Health Canada for Silenor (doxepin) for the treatment and symptomatic relief of insomnia.
Although genetics is the most significant known determinant of human intelligence, how specific genes affect intelligence remains largely unknown. A multi-institution team led by a University of Utah USTAR researcher has found that the brain gene STX1A plays a significant role in the level of intelligence displayed by patients with Williams Syndrome.
› Verified 2 days ago
Lindsay Doran, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 766 Broad St, Shrewsbury, NJ 07702 Phone: 855-428-8246 | |
Miss Catherine Teruko Ishimasa, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 766 Broad St, Shrewsbury, NJ 07702 Phone: 855-428-8246 | |
Lori Gonzalez, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 54 N Park Ave, Shrewsbury, NJ 07702 Phone: 917-406-0478 | |
Carissa Clayton, OTR Occupational Therapist Medicare: Medicare Enrolled Practice Location: 166 Patterson Ave, Shrewsbury, NJ 07702 Phone: 732-842-6600 | |
Nicole Emily Ciocchi, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 54 N Park Ave, Shrewsbury, NJ 07702 Phone: 732-852-5311 | |
Serina Marie Figueiras, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 166 Patterson Ave Ste 8, Shrewsbury, NJ 07702 Phone: 732-842-6600 | |
Nicole Signore, OTD, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 766 Broad St, Shrewsbury, NJ 07702 Phone: 855-428-8246 |